TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11380276

Group type: EXPERIMENTAL
Intervention: Static stretching protocol only (group 2)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Active heel raises before stretching (group 3)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Superficial, moist heat to the plantar‐flexor muscles before stretching (group 4)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Continuous ultrasound for 7 minutes before stretching (group 5)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (group 1)
Number of subjects: 97
Study: 9211466

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: UF-021
Number of subjects: 9
Study: 7705376

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) at rest
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) during exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) during recovery from exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) at rest with induced acidosis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) at rest with induced alkalosis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) during acidosis
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral [13C]bicarbonate (0.1 mg kg‐1) during alkalosis
Number of subjects: 10
Study: 3314521

Group type: EXPERIMENTAL
Intervention: Meclofenamate sodium, 100 mg by mouth, three times a day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 2195864

Group type: EXPERIMENTAL
Intervention: Oxygenated Fluosol perfusion
Number of subjects: 245

Group type: COMPARATOR
Intervention: Routine angioplasty
Number of subjects: 245
Study: 1098526

Group type: EXPERIMENTAL
Intervention: Albuterol aerosol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isoproterenol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31112371

Group type: EXPERIMENTAL
Intervention: small-spot IMPT
Number of subjects: 35

Group type: COMPARATOR
Intervention: VMAT
Number of subjects: 35
Study: 28735173

Group type: EXPERIMENTAL
Intervention: Detached mindfulness (DM; group treatment, twice weekly)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Leisure activities (control condition, twice weekly)
Number of subjects: 34
Study: 26346941

Group type: EXPERIMENTAL
Intervention: NBI-98854 (25 mg to 75 mg, once daily)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: NBI-98854
Number of subjects: 102
Study: 24093950

Group type: EXPERIMENTAL
Intervention: Accelerated initiation of renal replacement therapy (within 12 hours of eligibility)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard initiation of renal replacement therapy (monitored over 7 days)
Number of subjects: 100
Study: 22030769

Group type: EXPERIMENTAL
Intervention: Functional constipation group (FC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study: 19636689

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d orally
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 17257992

Group type: EXPERIMENTAL
Intervention: MECC system (n = 17)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard cardiopulmonary bypass (n = 23)
Number of subjects: 40
Study: 15040515

Group type: EXPERIMENTAL
Intervention: Hispanics
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: White European admixture among Hispanics
Number of subjects: 908

Group type: COMPARATOR
Intervention: White European admixture among non-Hispanic blacks
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Hispanic blacks
Number of subjects: 908
Study: 11203770

Group type: EXPERIMENTAL
Intervention: Polyacid-modified resin composite
Number of subjects: 34

Group type: COMPARATOR
Intervention: Resin-modified glass-ionomer restorative material
Number of subjects: 34
Study: 9754450

Group type: EXPERIMENTAL
Intervention: 1 mg of alprazolam
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8154558

Group type: EXPERIMENTAL
Intervention: Sending a reminder postcard
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mailing the recommendation letter from each woman's primary care physician
Number of subjects: 0
Study: 3042939

Group type: EXPERIMENTAL
Intervention: Pancrease (8 capsules daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Eurobiol (2 bottles daily)
Number of subjects: 11
Study: 30912160

Group type: EXPERIMENTAL
Intervention: Telephone Intervention Problem Solving (TIPS) for 2 months
Number of subjects: 45

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 45
Study: 31450908

Group type: EXPERIMENTAL
Intervention: Breast cancer screening adoption stages (pre-contemplation, contemplation, preparation, action, maintenance)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Positive family history of breast cancer
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Perceived susceptibility
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Perceived severity
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Knowledge of symptoms
Number of subjects: 334
Study: 28346719

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. lactis Bb‐12, Lactobacillus acidophilus La‐5)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415
Study: 25171898

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt plus probiotic capsules
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt plus placebo capsules
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control milk plus probiotic capsules
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control milk plus placebo capsules
Number of subjects: 156
Study: 21883985

Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spectacles with Bangerter filters
Number of subjects: 80
Study: 21150558

Group type: EXPERIMENTAL
Intervention: Boosted protease inhibitors (any of the regimens including LPV/r)
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Nonboosted protease inhibitors
Number of subjects: 3719

Group type: EXPERIMENTAL
Intervention: Interruption of protease inhibitor regimens
Number of subjects: 3719

Group type: COMPARATOR
Intervention: NNRTI-based regimen
Number of subjects: 3719
Study: 18429758

Group type: EXPERIMENTAL
Intervention: Metformin (n=29)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Continual treatment with Metformin for 12 months (n=30)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual treatment (Control group, n=12)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Patients never treated with Metformin (n=8)
Number of subjects: 81
Study: 16492274

Group type: EXPERIMENTAL
Intervention: Radial artery harvesting (study group)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 14640237

Group type: EXPERIMENTAL
Intervention: Candesartan (4 to 8 mg once-daily) added to ramipril (5 - 7.5 mg/day) for 16 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo added to ramipril (5 - 7.5 mg/day) for 16 weeks
Number of subjects: 32
Study: 10758305

Group type: EXPERIMENTAL
Intervention: Alternating chemoradiotherapy or partly accelerated radiotherapy
Number of subjects: 115

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 115
Study: 8620276

Group type: EXPERIMENTAL
Intervention: Preoperative infusion cholangiography (PIC)
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Intraoperative cholangiography (IOC)
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Bile duct exploration
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Cholecystectomy alone
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 1042
Study: 1478806

Group type: EXPERIMENTAL
Intervention: Anal dilatation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lateral subcutaneous sphincterotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haemorrhoidectomy
Number of subjects: 0
Study: 6369522

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g/day) + Intensive antacid treatment
Number of subjects: 81

Group type: COMPARATOR
Intervention: Cimetidine (1 g/day) + Placebo treatment
Number of subjects: 81
Study: 31600383

Group type: EXPERIMENTAL
Intervention: Urine Tenofovir Concentrations
Number of subjects: 0
Study: 29775203

Group type: EXPERIMENTAL
Intervention: Optimal dynamic treatment regime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Support vector machines classification technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential, multiple assignment randomized clinical trial
Number of subjects: 0
Study: 27435163

Group type: EXPERIMENTAL
Intervention: Metformin 1,000 mg twice daily
Number of subjects: 500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study: 24239662

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 19184

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 19184
Study: 22356669

Group type: EXPERIMENTAL
Intervention: Cannabis-dependent patients
Number of subjects: 242

Group type: COMPARATOR
Intervention: Cocaine-dependent patients
Number of subjects: 242
Study: 21049213

Group type: EXPERIMENTAL
Intervention: Phone calls
Number of subjects: 354

Group type: COMPARATOR
Intervention: No phone calls
Number of subjects: 354
Study: 18503642

Group type: EXPERIMENTAL
Intervention: High‐intensive EoP intervention (counseling and supervised exercise) - 4 months of group‐based supervised training and five motivational counseling sessions.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Low‐intensive intervention (counseling) - attended four motivational counseling sessions.
Number of subjects: 52
Study: 15671108

Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate diet (n = 22)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Low-fat diet (n = 19)
Number of subjects: 41
Study: 12181246

Group type: EXPERIMENTAL
Intervention: Docetaxel (100 mg/m²) followed by AC (60/600 mg/m²)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: AC (60/600 mg/m²) followed by Docetaxel (100 mg/m²)
Number of subjects: 33
Study: 10359886

Group type: EXPERIMENTAL
Intervention: AA-2414 (80 mg/day)
Number of subjects: 31
Study: 7732331

Group type: EXPERIMENTAL
Intervention: Pantoprazole (40 mg before breakfast)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Ranitidine (300 mg at bedtime)
Number of subjects: 248
Study: 1695449

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA, Aspirin) challenge
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo test
Number of subjects: 17
Study: 108734

Group type: EXPERIMENTAL
Intervention: Intravenous THC, 30‐‐44.8 microgram/kg
Number of subjects: 4

Group type: COMPARATOR
Intervention: Combined autonomic blockade (i.v. saline, 0.04 mg/kg atropine sulfate, 0.2 mg/kg propranolol, or both)
Number of subjects: 4
Study: 31786980

Group type: EXPERIMENTAL
Intervention: Serum urate level ≥6.8 mg/dL (hyperuricemia)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Serum urate level 6.0 to <6.8 mg/dL
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Apparent treatment-resistant hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg on 3 antihypertensive medications or use of ≥4 antihypertensive medications)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Number of antihypertensive medication classes
Number of subjects: 900

Group type: COMPARATOR
Intervention: Serum urate level <6.0 mg/dL (reference)
Number of subjects: 900
Study: 30876658

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate
Number of subjects: 99
Study: 27120192

Group type: EXPERIMENTAL
Intervention: Kinematic alignment with custom-made cutting guides
Number of subjects: 200

Group type: COMPARATOR
Intervention: Mechanical alignment (control group)
Number of subjects: 200
Study: 26651344

Group type: EXPERIMENTAL
Intervention: Care pathway based on urodynamic tests with invasive multichannel cystometry
Number of subjects: 100

Group type: COMPARATOR
Intervention: Care pathway based on non-invasive routine tests
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Invasive urodynamics
Number of subjects: 100
Study: 24456787

Group type: EXPERIMENTAL
Intervention: Terazosin plus Tolterodine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Terazosin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Tolterodine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 20473950

Group type: EXPERIMENTAL
Intervention: Solar vitamin D effective UV radiation (VD dose)
Number of subjects: 41811

Group type: EXPERIMENTAL
Intervention: Dietary vitamin D intake
Number of subjects: 41811

Group type: EXPERIMENTAL
Intervention: Sun-seeking holidays
Number of subjects: 41811

Group type: EXPERIMENTAL
Intervention: Use of solarium
Number of subjects: 41811

Group type: EXPERIMENTAL
Intervention: Frequency of sunburn
Number of subjects: 41811
Study: 19049753

Group type: EXPERIMENTAL
Intervention: ET‐AR antagonist (sitaxsentan) 1 mg/kg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ET‐AR antagonist (sitaxsentan) higher doses
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: ET‐AR antagonist (sitaxsentan)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Vehicle (control group)
Number of subjects: 44
Study: 16972512

Group type: EXPERIMENTAL
Intervention: Restrictive indoor smoking policy
Number of subjects: 14237

Group type: EXPERIMENTAL
Intervention: Restrictive outdoor smoking policy
Number of subjects: 14237

Group type: EXPERIMENTAL
Intervention: Desire to breathe clean air vs. desire to smoke
Number of subjects: 14237
Study: 14624406

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (high-CHO: 58% of energy as CHO)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid diet (high-MUFA: fat, 40% of energy and 22% as MUFA)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (high-CHO)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid diet (high-MUFA)
Number of subjects: 65
Study: 10919606

Group type: EXPERIMENTAL
Intervention: Detection of HHV‐7 DNA in peripheral blood leucocytes
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: CMV disease
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Donor-recipient CMV serostatus
Number of subjects: 37
Study: 1445448

Group type: EXPERIMENTAL
Intervention: 10-deazaaminopterin (10-DAM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 18
Study: 4081994

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no psychological intervention)
Number of subjects: 90
Study: 30979610

Group type: EXPERIMENTAL
Intervention: Hyperhomocysteinaemia (HHCY) group
Number of subjects: 936

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome group
Number of subjects: 936
Study: 29075782

Group type: EXPERIMENTAL
Intervention: Participatory organizational-level workplace intervention
Number of subjects: 404

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 404
Study: 26703220

Group type: EXPERIMENTAL
Intervention: Metformin 500mg twice daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Ethinyl estradiol-cyproterone acetate for 21 days followed by 7 days drug-free
Number of subjects: 26
Study: 24673793

Group type: EXPERIMENTAL
Intervention: Walnuts (28.4 g, 6/week)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: n-3 FA enriched egg (6/week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard egg (6/week)
Number of subjects: 20
Study: 23154392

Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted colon resection (LCR)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Open colon resection (OCR)
Number of subjects: 601
Study: 20726911

Group type: EXPERIMENTAL
Intervention: ProTaper Retreatment files
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mtwo Retreatment files
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Twisted Files
Number of subjects: 90

Group type: COMPARATOR
Intervention: Resilon/Real Seal
Number of subjects: 90

Group type: COMPARATOR
Intervention: gutta-percha/AH plus
Number of subjects: 90
Study: 18796688

Group type: COMPARATOR
Intervention: 1-minute balloon inflation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3-minute balloon inflation
Number of subjects: 48
Study: 15802405

Group type: EXPERIMENTAL
Intervention: Unopposed transdermal estradiol (14 microg per day)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 417
Study: 12161495

Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg daily with fatty liver (group C)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg daily without fatty liver (group B)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No tamoxifen (group A)
Number of subjects: 39
Study: 10210764

Group type: EXPERIMENTAL
Intervention: Oral granisetron 1 mg twice a day on day 1, followed by metoclopramide 60 mg on day 2 and 3
Number of subjects: 198

Group type: COMPARATOR
Intervention: Intravenous ondansetron 8 mg on day 1, followed by ondansetron 8 mg tablet twice a day on day 2 and 3
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Oral granisetron followed by metoclopramide
Number of subjects: 198

Group type: COMPARATOR
Intervention: Intravenous plus oral ondansetron
Number of subjects: 198
Study: 8540613

Group type: EXPERIMENTAL
Intervention: Neoadjuvant combination therapy with flutamide and an LHRH agonist for 3 months
Number of subjects: 96
Study: 1945205

Group type: EXPERIMENTAL
Intervention: Topical dihydrotestosterone
Number of subjects: 5

Group type: COMPARATOR
Intervention: Vehicle alone (Control)
Number of subjects: 5
Study: 6842586

Group type: EXPERIMENTAL
Intervention: Shuffled sequence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Representative sequence
Number of subjects: 0
Study: 30074050

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 410

Group type: COMPARATOR
Intervention: High-quality usual care
Number of subjects: 410
Study: 30261474

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 3977

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3977

Group type: EXPERIMENTAL
Intervention: Cathepsin B
Number of subjects: 3977

Group type: EXPERIMENTAL
Intervention: Cathepsin S
Number of subjects: 3977
Study: 27041692

Group type: EXPERIMENTAL
Intervention: Low-dose cyclophosphamide plus G-CSF (Arm A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: G-CSF alone (Arm B)
Number of subjects: 38
Study: 25291725

Group type: EXPERIMENTAL
Intervention: Suvorexant
Number of subjects: 0
Study: 22325127

Group type: EXPERIMENTAL
Intervention: Suubi intervention
Number of subjects: 283
Study: 19923998

Group type: EXPERIMENTAL
Intervention: Structured patient group education (IBS school)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Written information (guidebook)
Number of subjects: 143
Study: 17356317

Group type: EXPERIMENTAL
Intervention: O6MWT (walking test with supplemental oxygen)
Number of subjects: 31

Group type: COMPARATOR
Intervention: A6MWT (walking test in room-air conditions)
Number of subjects: 31
Study: 16330684

Group type: EXPERIMENTAL
Intervention: Candesartan at a target dose of 32 mg once daily
Number of subjects: 7599

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 7599
Study: 12480442

Group type: COMPARATOR
Intervention: Pramipexole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ropinirole
Number of subjects: 0
Study: 10458211

Group type: EXPERIMENTAL
Intervention: Carboplatin at 100 mg/m2/wk concurrent with radiation therapy
Number of subjects: 283

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 283
Study: 7597774

Group type: EXPERIMENTAL
Intervention: Plasma-derived vaccine (0.5 ml, 10 micrograms HBsAg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Plasma-derived vaccine (0.5 ml, 25 micrograms HBsAg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Yeast-derived recombinant hepatitis B vaccine (0.5 ml, 10 micrograms HBsAg)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Hevac B (0.5 ml)
Number of subjects: 78
Study: 1754656

Group type: EXPERIMENTAL
Intervention: bright white light (2,500 lx)
Number of subjects: 42

Group type: COMPARATOR
Intervention: dim red light (50 lx)
Number of subjects: 42
Study: 6805026

Group type: EXPERIMENTAL
Intervention: 100 mg CERM 3726
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 200 mg CERM 3726
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 300 mg CERM 3726
Number of subjects: 6
Study: 30427054

Group type: EXPERIMENTAL
Intervention: Midlateral subacromial injection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Posterior subacromial injection
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Midlateral and Posterior)
Number of subjects: 50
Study: 27943533

Group type: EXPERIMENTAL
Intervention: Treatment for anorexia nervosa (AN)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Caregivers of more severely ill patients
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Mothers of adolescent AN patients
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Follow-up at 2.5 years
Number of subjects: 170
Study: 24844869

Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/d)
Number of subjects: 56
Study: 25610505

Group type: EXPERIMENTAL
Intervention: BAL (Bronchoalveolar Lavage)
Number of subjects: 73

Group type: COMPARATOR
Intervention: EA (Endotracheal Aspiration)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: BAL
Number of subjects: 73

Group type: COMPARATOR
Intervention: EA
Number of subjects: 73
Study: 22738209

Group type: EXPERIMENTAL
Intervention: 200-ml sports drink with 1 g of GABA (trial G)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 200-ml sports drink without GABA (trial C)
Number of subjects: 8
Study: 20035589

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX) treatment for 6 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 21
Study: 17339106

Group type: EXPERIMENTAL
Intervention: Integrated Care (IC)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 113